News for 'medical innovation'

NIMS Reaches 2,000 Kidney Transplants Milestone

NIMS Reaches 2,000 Kidney Transplants Milestone

Rediff.com22 May 2026

The Nizam's Institute of Medical Sciences (NIMS) in Hyderabad has achieved a significant milestone by completing 2,000 kidney transplants, making it one of the leading institutions in India for this procedure. The majority of these transplants were performed free of cost under government schemes.

Neena Kulkarni: 'Vijaya Bai Taught Us The Magic Moments Of Acting'

Neena Kulkarni: 'Vijaya Bai Taught Us The Magic Moments Of Acting'

Rediff.com9 Jul 2026

'She taught us that acting wasn't something people did because they couldn't do anything else. It was a skill. A skill that needed to be constantly polished and shaped, and the respect you command with that.'

Delhi Hospital Tackles Complex Endometriosis Case

Delhi Hospital Tackles Complex Endometriosis Case

Rediff.com31 May 2026

A Delhi hospital has successfully operated on a woman with advanced endometriosis, highlighting the challenges of treating the condition after multiple previous surgeries.

US Team Likely to Visit India in June for Crucial Trade Discussions

US Team Likely to Visit India in June for Crucial Trade Discussions

Rediff.com21 May 2026

Commerce and Industry Minister Piyush Goyal announced that a US team is expected to visit India next month for trade talks, following an earlier Indian delegation's visit to Washington, DC, in April to finalise an interim pact and advance negotiations for a broader bilateral trade agreement.

Study Finds AI Chatbots Provide Inaccurate Health Advice

Study Finds AI Chatbots Provide Inaccurate Health Advice

Rediff.com15 Apr 2026

A new study reveals that AI chatbots often provide inaccurate and incomplete medical information, raising concerns about their use in healthcare communication.

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Rediff.com20 Apr 2026

The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.

AIIMS Delhi's Surgical Advance Offers Hope For Spinal Deformities

AIIMS Delhi's Surgical Advance Offers Hope For Spinal Deformities

Rediff.com3 May 2026

A modified surgical technique developed at AIIMS, Delhi, is providing new hope for patients with severe spinal deformities. The technique, a refined version of posterior vertebral column resection (PVCR), improves spinal stability and reduces complications, leading to better outcomes and improved quality of life for patients.

Budget 2026 Treats Healthcare As Strategic National Capability

Budget 2026 Treats Healthcare As Strategic National Capability

Rediff.com4 Feb 2026

The Budget reframes healthcare as a strategic national capability, backing biopharma innovation, workforce expansion and technology-led governance to power India's next growth phase.

IIT Kharagpur to Open School of Digital Learning, AI and Machine Learning

IIT Kharagpur to Open School of Digital Learning, AI and Machine Learning

Rediff.com3 Mar 2026

The Indian Institute of Technology Kharagpur has announced the launch of a new school dedicated to digital learning, applied artificial intelligence, and machine learning, supported by a significant philanthropic commitment.

Centre Cracks Down on GLP-1 Drug Misuse

Centre Cracks Down on GLP-1 Drug Misuse

Rediff.com25 Mar 2026

Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.

Budget 2026: Time To Fix The Weak Link In R&D Ecosystem

Budget 2026: Time To Fix The Weak Link In R&D Ecosystem

Rediff.com31 Jan 2026

Restoring weighted tax deductions and adopting a petty patents regime can foster firm-level innovative activity critical for competitiveness, points out Nagesh Kumar.

Indian pharma to get stronger dose of EU mkt access

Indian pharma to get stronger dose of EU mkt access

Rediff.com5 Feb 2026

The European Union's (EU's) offer to slash tariffs on 97.5 per cent of Indian chemical exports to zero is set to give India's pharmaceutical and medical device firms preferential access to the European markets.

Hyderabad claims its place as global MNC destination

Hyderabad claims its place as global MNC destination

Rediff.com18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.

London Surgeon Completes First UK Remote Robotic Surgeries in Gibraltar

London Surgeon Completes First UK Remote Robotic Surgeries in Gibraltar

Rediff.com6 Mar 2026

A London-based surgeon of Indian origin has made medical history by successfully completing the UK's first remote robotic surgeries on patients in Gibraltar, approximately 2,400 km away.

As Iran Tensions Surge, India Leans On UAE

As Iran Tensions Surge, India Leans On UAE

Rediff.com13 Apr 2026

For India, much is at stake: Crucial energy supplies traversing the Strait of Hormuz, the fate of its 10 million citizens living and working in West Asia -- who send generous remittances home -- and its major trade links with the region.

Prolonged Sanitary Pad Use Linked to Vaginal Issues: Experts Suggest Moringa Infusion

Prolonged Sanitary Pad Use Linked to Vaginal Issues: Experts Suggest Moringa Infusion

Rediff.com17 Mar 2026

Experts warn that prolonged use of sanitary pads, especially in humid climates, can disrupt the vaginal microbiome, leading to bacterial vaginosis. Moringa-infused pads may offer a solution due to their anti-inflammatory and antimicrobial properties.

Budget 2026 boosts healthcare spend, drugs relief

Budget 2026 boosts healthcare spend, drugs relief

Rediff.com1 Feb 2026

The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.

Biotechnology Facility Foundation Laid in Thiruvananthapuram

Biotechnology Facility Foundation Laid in Thiruvananthapuram

Rediff.com1 Mar 2026

Union Minister Jitendra Singh inaugurated a new biotechnology facility and dedicated a national facility for recombinant cells and sensors at the Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, highlighting India's focus on biotechnology and its potential for economic growth.

Siddaramaiah Calls for Ethical AI Use, Protecting Artists in AVGC-XR

Siddaramaiah Calls for Ethical AI Use, Protecting Artists in AVGC-XR

Rediff.com27 Feb 2026

Karnataka Chief Minister Siddaramaiah emphasized the importance of ethical AI usage, intellectual property protection, and fair compensation in the AVGC-XR sector, advocating for AI to enhance human creativity rather than replace artists.

What is India-US interim trade deal all about. Here are the details

What is India-US interim trade deal all about. Here are the details

Rediff.com7 Feb 2026

US and India will promptly implement this framework and work towards finalising the interim agreement with a view to concluding a mutually beneficial bilateral trade agreement.

Ambitious, futuristic: PM Modi lauds Sitharaman's 9th Budget

Ambitious, futuristic: PM Modi lauds Sitharaman's 9th Budget

Rediff.com1 Feb 2026

Reiterating Sitharaman's statement that this is a youth power budget, Modi emphasised that the provisions made in the budget will prepare leaders, innovators and creators across different sectors.

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

What India gives, and what it gets: Highlights of India-US interim trade deal

What India gives, and what it gets: Highlights of India-US interim trade deal

Rediff.com7 Feb 2026

Both countries commit to provide each other preferential market access in sectors of respective interest on a sustained basis

Modi moves to new PMO, Seva Teerth; takes 1st decision on...

Modi moves to new PMO, Seva Teerth; takes 1st decision on...

Rediff.com13 Feb 2026

Prime Minister Narendra Modi inaugurated the Seva Teerth complex, which will house the Prime Minister's Office (PMO), the National Security Council Secretariat, and the Cabinet Secretariat, marking a shift towards modernizing India's administrative governance.

Ex-bus conductor, paediatrician among 45 Padma Shri 'unsung heroes'

Ex-bus conductor, paediatrician among 45 Padma Shri 'unsung heroes'

Rediff.com25 Jan 2026

India announces Padma Shri awards for 45 individuals, recognizing 'unsung heroes' like a former bus conductor who created the world's largest free library and a pediatrician who established Asia's first human milk bank.

10 Must Watch Movies From Around The World

10 Must Watch Movies From Around The World

Rediff.com25 Feb 2026

Aseem Chhabra lists his top 10 films from this year's Sundance festival, a blend of narratives and documentaries made in the US and other parts of the world.

SC questions delay as Centre says Wangchuk getting 'best treatment'

SC questions delay as Centre says Wangchuk getting 'best treatment'

Rediff.com9 Feb 2026

The Supreme Court is reviewing the detention of climate activist Sonam Wangchuk under the National Security Act, considering his health condition and allegations of inciting unrest in Ladakh.

10 Stocks That May Gain From Budget

10 Stocks That May Gain From Budget

Rediff.com4 Feb 2026

The fiscal tilt towards capex benefits companies in investment-related sectors like capital goods, defence equipment, engineering & construction and metal & mining. The planned cut in revenue expenditure will weigh on companies in consumption sectors like FMCG, consumer durables and retail.

Union Budget 2025: Will 10K new medical seats curb students outflow?

Union Budget 2025: Will 10K new medical seats curb students outflow?

Rediff.com2 Feb 2025

The Indian government's announcement of 10,000 additional seats in medical colleges next year, part of a plan to add 75,000 seats over five years, has been welcomed by education experts and stakeholders. The move aims to address the shortage of medical professionals and reduce the outflow of Indian medical students to other countries. The budget also includes infrastructure expansion at five new IITs to accommodate 6,500 more students and an allocation of Rs 500 crore to set up a Centre of Excellence in Artificial Intelligence for education.

Mothers Against Vaping Launches Edu Toolkit

Mothers Against Vaping Launches Edu Toolkit

Rediff.com17 Nov 2025

The kit is aimed at building awareness among children about the hazards of new-age gateway nicotine devices such as nicotine gums, pouches and vapes.

Tath Kana Review: Inspiring Tale Of Passion And Purpose

Tath Kana Review: Inspiring Tale Of Passion And Purpose

Rediff.com28 Nov 2025

We may not know Dr Ramani at first, but by the end, we get a clearer sense of his nobility. For a biopic, that's a job done well, notes Mayur Sanap.

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

Making Robots To Help Humanity

Making Robots To Help Humanity

Rediff.com24 Nov 2025

'Our vision is to innovate as many products as we can and solve as many problems as possible.'

One-Regulator Education Bill Sent To Panel

One-Regulator Education Bill Sent To Panel

Rediff.com16 Dec 2025

'It interferes in administrative matters of institutions, robbing them of their independence in day-to-day affairs and appointments.'

BSE 100 companies boost R&D, innovation challenges persist

BSE 100 companies boost R&D, innovation challenges persist

Rediff.com13 Oct 2024

Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period in-between, according to data compiled from Bloomberg and company annual reports. Also, these companies more than doubled their R&D spending in absolute terms over these five years: From Rs 25,041 crore to Rs 63,072 crore. While this reflects a prioritisation of innovation, corporate R&D investment remains relatively conservative.

India's Hottest Jobs In 2026

India's Hottest Jobs In 2026

Rediff.com26 Nov 2025

Across all sectors, the future of work depends on adaptability.

Protein Craze Sweeps India

Protein Craze Sweeps India

Rediff.com10 Oct 2025

How much protein is needed for a healthy daily diet? A healthy adult needs a minimum of 0.80 gram of protein for every kilogramme of body weight per day. The average consumption of protein in India is around 62 gm per day, which is way lower than the global average of 78 gm.

Is Pharmaceutical Engg Better Than BPham And PharmD?

Is Pharmaceutical Engg Better Than BPham And PharmD?

Rediff.com11 Nov 2025

rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.

Will Cancer Soon Be Defeated?

Will Cancer Soon Be Defeated?

Rediff.com18 Nov 2025

There is a decisive shift in how cancer may soon be confronted and, hopefully, defeated.

Why Hospitals Are Spending Money On IT

Why Hospitals Are Spending Money On IT

Rediff.com11 Sep 2025

60 per cent of hospitals are directing investments towards IT capability building, 50 per cent towards business intelligence tools and data lakes, and a significant share into AI-led use cases such as clinical documentation (72 per cent), decision support systems (64 per cent) and imaging (60 per cent).